Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
164.17
+8.73 (5.62%)
Jan 30, 2025, 4:00 PM EST - Market closed
Quest Diagnostics Employees
Quest Diagnostics had 48,000 employees as of December 31, 2023. The number of employees decreased by 1,000 or -2.04% compared to the previous year.
Employees
48,000
Change (1Y)
-1,000
Growth (1Y)
-2.04%
Revenue / Employee
$205,667
Profits / Employee
$18,146
Market Cap
18.32B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 48,000 | -1,000 | -2.04% |
Dec 31, 2022 | 49,000 | 0 | - |
Dec 31, 2021 | 49,000 | 0 | - |
Dec 31, 2020 | 49,000 | 2,000 | 4.26% |
Dec 31, 2019 | 47,000 | 1,000 | 2.17% |
Dec 31, 2018 | 46,000 | 1,000 | 2.22% |
Dec 31, 2017 | 45,000 | 2,000 | 4.65% |
Dec 31, 2016 | 43,000 | -1,000 | -2.27% |
Dec 31, 2015 | 44,000 | -1,000 | -2.22% |
Dec 31, 2014 | 45,000 | 4,000 | 9.76% |
Dec 31, 2013 | 41,000 | 0 | - |
Dec 31, 2012 | 41,000 | -1,000 | -2.38% |
Dec 31, 2011 | 42,000 | 0 | - |
Dec 31, 2010 | 42,000 | -1,000 | -2.33% |
Dec 31, 2009 | 43,000 | 200 | 0.47% |
Dec 31, 2008 | 42,800 | -700 | -1.61% |
Dec 31, 2007 | 43,500 | 2,500 | 6.10% |
Dec 31, 2006 | 41,000 | -500 | -1.20% |
Dec 31, 2005 | 41,500 | 2,900 | 7.51% |
Dec 31, 2004 | 38,600 | 1,400 | 3.76% |
Dec 31, 2003 | 37,200 | 3,800 | 11.38% |
Dec 31, 2002 | 33,400 | 4,400 | 15.17% |
Dec 31, 2001 | 29,000 | 2,000 | 7.41% |
Dec 31, 2000 | 27,000 | 0 | - |
Dec 31, 1999 | 27,000 | 12,000 | 80.00% |
Dec 31, 1998 | 15,000 | -1,300 | -7.98% |
Dec 31, 1997 | 16,300 | -1,500 | -8.43% |
Dec 31, 1996 | 17,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
DGX News
- 2 hours ago - Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year - PRNewsWire
- 4 hours ago - Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 12 hours ago - Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share - PRNewsWire
- 3 days ago - Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals - PRNewsWire
- 22 days ago - Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer - PRNewsWire
- 4 weeks ago - Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 - PRNewsWire
- 2 months ago - Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference - PRNewsWire
- 2 months ago - Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health - PRNewsWire